The Decreased N6-methyladenine DNA Modification in Cancer Cells.

Da Liang,Hong Wang,Wei Song,Xin Xiong,Xianhua Zhang,Zhiping Hu,Huahu Guo,Zhenjun Yang,Suodi Zhai,Li-He Zhang,Min Ye,Quan Du

DOI: https://doi.org/10.1016/j.bbrc.2016.09.136

IF: 3.1

2016-01-01

Biochemical and Biophysical Research Communications

Abstract:N6-methyladenine (6 mA) is a recently characterized DNA modification in mammalian genomes, although its biological importance remains to be resolved. Using a highly sensitive HPLC/MS/MS approach, here we report regulation of 6 mA modification in mammalian cells. To these aspects, down-regulation of 6 mA modification was first characterized in human cancer cells and tissues, relative to their normal controls. In contrast to the relative stable 5 mC modification, a dramatic decrease of 6 mA modification was found, showing that 6 mA is the most regulated DNA modification in cancers. In addition to the regulation in cancer cells, a hundreds-fold increase of 6 mA modification was found for in vitro cultured human cells, relative to the in vivo cells. This up-regulation was also confirmed with in vitro cultured mouse cells. Taken together, our study revealed distinct 6 mA modification profiles in the cancer and cultured cells. Considering its distinct regulation from that of 5 mC, our study suggests that 6 mA DNA modification may play a crucial role in cell fate transition of mammalian cells.